L22 ribosomal protein and effect of its mutation on ribosome resistance to erythromycin.

Natalia Davydova, Victor Streltsov, Matthew Wilce, Anders Liljas, Maria Garber

Institute of Protein Research, Moscow Region 142 290, Pushchino, Russia. ndavyd@cyllene.uwa.edu.au

Journal of molecular biology 2002 Sep 20

filter terms:

The ribosomal protein L22 is a core protein of the large ribosomal subunit interacting with all domains of the 23S rRNA. The triplet Met82-Lys83-Arg84 deletion in L22 from Escherichia coli renders cells resistant to erythromycin which is known as an inhibitor of the nascent peptide chain elongation. The crystal structure of the Thermus thermophilus L22 mutant with equivalent triplet Leu82-Lys83-Arg84 deletion has been determined at 1.8A resolution. The superpositions of the mutant and the wild-type L22 structures within the 50S subunits from Haloarcula marismortui and Deinococcus radiodurans show that the mutant beta-hairpin is bent inward the ribosome tunnel modifying the shape of its narrowest part and affecting the interaction between L22 and 23S rRNA. 23S rRNA nucleotides of domain V participating in erythromycin binding are located on the opposite sides of the tunnel and are brought to those positions by the interaction of the 23S rRNA with the L22 beta-hairpin. The mutation in the L22 beta-hairpin affects the orientation and distances between those nucleotides. This destabilizes the erythromycin-binding "pocket" formed by 23S rRNA nucleotides exposed at the tunnel surface. It seems that erythromycin, while still being able to interact with one side of the tunnel but not reaching the other, is therefore unable to block the polypeptide growth in the drug-resistant ribosome.

Citation

Natalia Davydova, Victor Streltsov, Matthew Wilce, Anders Liljas, Maria Garber. L22 ribosomal protein and effect of its mutation on ribosome resistance to erythromycin. Journal of molecular biology. 2002 Sep 20;322(3):635-44